Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age

Intensive investigation of cardiovascular disease (CVD) risk factors (RFs), both traditional (smoking, dyslipidemia, diabetes, etc.) and non-traditional, which are a component of the so-called exposome, as well as their non-drug and drug correction provide wide prospects for effective cardiovascular...

Full description

Bibliographic Details
Main Authors: O. V. Kopylova, A. I. Ershova, A. N. Meshkov, A. V. Kontsevaya, O. M. Drapkina
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2021-11-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2991
_version_ 1797882313745367040
author O. V. Kopylova
A. I. Ershova
A. N. Meshkov
A. V. Kontsevaya
O. M. Drapkina
author_facet O. V. Kopylova
A. I. Ershova
A. N. Meshkov
A. V. Kontsevaya
O. M. Drapkina
author_sort O. V. Kopylova
collection DOAJ
description Intensive investigation of cardiovascular disease (CVD) risk factors (RFs), both traditional (smoking, dyslipidemia, diabetes, etc.) and non-traditional, which are a component of the so-called exposome, as well as their non-drug and drug correction provide wide prospects for effective cardiovascular prevention. Prevention becomes the dominant trend in cardiology and in medicine in general. The aim of the article was to describe cardiovascular prevention in young, middle, elderly and senile age. Due to the multifaceted nature of cardiovascular RFs, an integrated biopsychosocial approach, individual and population-based prevention, cumulative risk assessment of all CVDs, intersectoral collaboration and the involvement of decision-makers, are key to the success and effectiveness of prevention measures. It is important to note that, on the one hand, preventive measures should be started as early as possible due to cumulative effect of RFs, on the other hand, most of the preventive interventions for CVD are extremely relevant at all life stages.
first_indexed 2024-04-10T03:33:50Z
format Article
id doaj.art-34838ac1421f4fcdaccaa52b19e12cb4
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:33:50Z
publishDate 2021-11-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-34838ac1421f4fcdaccaa52b19e12cb42023-03-13T07:23:31Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252021-11-0120710.15829/1728-8800-2021-29912373Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile ageO. V. Kopylova0A. I. Ershova1A. N. Meshkov2A. V. Kontsevaya3O. M. Drapkina4ФГБУ “Национальный медицинский исследовательский центр терапии и профилактической медицины” Минздрава РоссииФГБУ “Национальный медицинский исследовательский центр терапии и профилактической медицины” Минздрава РоссииФГБУ “Национальный медицинский исследовательский центр терапии и профилактической медицины” Минздрава РоссииФГБУ “Национальный медицинский исследовательский центр терапии и профилактической медицины” Минздрава РоссииФГБУ “Национальный медицинский исследовательский центр терапии и профилактической медицины” Минздрава РоссииIntensive investigation of cardiovascular disease (CVD) risk factors (RFs), both traditional (smoking, dyslipidemia, diabetes, etc.) and non-traditional, which are a component of the so-called exposome, as well as their non-drug and drug correction provide wide prospects for effective cardiovascular prevention. Prevention becomes the dominant trend in cardiology and in medicine in general. The aim of the article was to describe cardiovascular prevention in young, middle, elderly and senile age. Due to the multifaceted nature of cardiovascular RFs, an integrated biopsychosocial approach, individual and population-based prevention, cumulative risk assessment of all CVDs, intersectoral collaboration and the involvement of decision-makers, are key to the success and effectiveness of prevention measures. It is important to note that, on the one hand, preventive measures should be started as early as possible due to cumulative effect of RFs, on the other hand, most of the preventive interventions for CVD are extremely relevant at all life stages.https://cardiovascular.elpub.ru/jour/article/view/2991профилактика сердечно-сосудистых заболеваниймолодойвзрослыйпожилой и старческий возрастэкспосомздоровьефакторы риска сердечно-сосудистых заболеваний
spellingShingle O. V. Kopylova
A. I. Ershova
A. N. Meshkov
A. V. Kontsevaya
O. M. Drapkina
Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age
Кардиоваскулярная терапия и профилактика
профилактика сердечно-сосудистых заболеваний
молодой
взрослый
пожилой и старческий возраст
экспосом
здоровье
факторы риска сердечно-сосудистых заболеваний
title Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age
title_full Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age
title_fullStr Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age
title_full_unstemmed Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age
title_short Lifetime prevention of cardiovascular disease. Part III: young, middle, elderly and senile age
title_sort lifetime prevention of cardiovascular disease part iii young middle elderly and senile age
topic профилактика сердечно-сосудистых заболеваний
молодой
взрослый
пожилой и старческий возраст
экспосом
здоровье
факторы риска сердечно-сосудистых заболеваний
url https://cardiovascular.elpub.ru/jour/article/view/2991
work_keys_str_mv AT ovkopylova lifetimepreventionofcardiovasculardiseasepartiiiyoungmiddleelderlyandsenileage
AT aiershova lifetimepreventionofcardiovasculardiseasepartiiiyoungmiddleelderlyandsenileage
AT anmeshkov lifetimepreventionofcardiovasculardiseasepartiiiyoungmiddleelderlyandsenileage
AT avkontsevaya lifetimepreventionofcardiovasculardiseasepartiiiyoungmiddleelderlyandsenileage
AT omdrapkina lifetimepreventionofcardiovasculardiseasepartiiiyoungmiddleelderlyandsenileage